| 1 |
LU0195948822 |
Franklin Biotechnology Discovery Fund - I (acc) USD |
+20,74 % |
+24,37 % |
0,77 |
| 2 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
+19,09 % |
+22,29 % |
0,77 |
| 3 |
LU0976566496 |
Franklin Biotechnology Discovery Fund - W (acc) USD |
+20,65 % |
+24,40 % |
0,76 |
| 4 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
+18,80 % |
+22,33 % |
0,75 |
| 5 |
LU0317020203 |
Candriam Equities L Biotechnology, V - Capitalisation |
+18,13 % |
+22,10 % |
0,73 |
|
|
| 79 |
LU2053353582 |
JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - CHF (hedged) |
-4,97 % |
+24,26 % |
-0,29 |
|
|
| 85 |
LU0415392678 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating |
-7,55 % |
+14,30 % |
-0,67 |
| 86 |
LU2719280096 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 CHF - Accumulating |
-8,38 % |
+14,65 % |
-0,71 |
| 87 |
LU0415392249 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating |
-8,19 % |
+14,29 % |
-0,71 |
| 88 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-8,49 % |
+14,64 % |
-0,72 |
| 89 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-9,13 % |
+14,64 % |
-0,76 |